Information on Methylin (Chewable Tablets of Methylphenidate) -

Information on Methylin (Chewable Tablets of Methylphenidate) –

Generic Name: Methylphenidate Chewable Tablets

Drug Class: CNS Stimulants


This medication has a risk of abuse and misuse. Only use Methylin (methylphenidate chewable tablets) as directed by your doctor. Inform your doctor if you have a history of drug or alcohol abuse.

Uses of Methylin

  • Treatment of attention deficit problems with hyperactivity
  • Treatment of narcolepsy
  • May be prescribed for other reasons. Consult with your doctor.
  • What to Tell Your Doctor Before Taking Methylin

    Inform your doctor if:

    • You are allergic to methylphenidate or any other component of Methylin (methylphenidate chewable tablets)
    • You have glaucoma, agitation, anxiety, or overactive thyroid
    • You or a family member have blood vessel disease, high blood pressure, heart structure problems or other heart problems, or Tourette’s syndrome or tics
    • You have ever had a stroke
    • You have taken certain drugs for depression or Parkinson’s disease in the last 14 days
    • You are taking linezolid or methylene blue
    • You have trouble swallowing
    • This is not a comprehensive list of all drugs or health problems that may interact with Methylin (methylphenidate chewable tablets). Inform your doctor and pharmacist about all medications, supplements, and health conditions you have before taking Methylin.

      What to Know While Taking Methylin

      While taking Methylin:

      • Inform all healthcare providers that you are taking Methylin
      • Avoid driving or performing tasks that require alertness until you know how Methylin affects you
      • Seek medical attention immediately if you experience symptoms such as fast, slow, or abnormal heartbeat; weakness on one side of the body; trouble speaking or thinking; change in balance; drooping on one side of the face; change in eyesight; chest pain or pressure; shortness of breath; or severe dizziness or passing out
      • You may need to undergo heart tests before starting Methylin
      • Check blood pressure and heart rate as directed by your doctor
      • Methylin may increase the risk of seizures in some people
      • Avoid consuming alcohol while taking Methylin
      • Inform your doctor if you have phenylketonuria (PKU)
      • Serotonin syndrome, a severe and sometimes deadly problem, may occur if you take Methylin with certain other drugs
      • Methylin may affect growth in children and teens in some cases
      • Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding
      • How to Take Methylin

        When taking Methylin:

        • Take as directed by your doctor
        • Chew well before swallowing
        • Take 30 to 45 minutes before meals
        • Take with a full glass of water
        • If taking more than once a day, take the last dose before 6 PM
        • If Methylin stops working well, contact your doctor before increasing the dosage
        • Avoid consuming caffeine and chocolate while taking Methylin
        • Side Effects to Report to Your Doctor Immediately

          Seek medical attention immediately if you experience any of the following:

          • Allergic reaction symptoms such as rash, hives, itching, difficulty breathing, or swelling of the face, lips, tongue, or throat
          • Signs of high blood pressure such as severe headache or dizziness, passing out, or changes in eyesight
          • Signs of liver problems such as dark urine, fatigue, loss of appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellowing of the skin or eyes
          • Joint pain
          • Purple patches on the skin or mouth
          • Seizures
          • Shakiness
          • Trouble controlling body movements
          • Sweating excessively
          • Restlessness
          • Change in color of hands or feet from pale to blue or red
          • Numbness, pain, tingling,
          • Leave a Reply

            Your email address will not be published. Required fields are marked *